Integra LifeSciences (IART) Misses Q3 EPS by 2c; Lowers Outlook

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/23/2026

1. META
2. TSLA
3. IBM
4. TXN
5. MRNA
6. SAP
7. CSX
8. LRCX
9. MRK
10. LVS

Go back to Integra LifeSciences (IART) Misses Q3 EPS by 2c; Lowers Outlook

Wells Fargo Downgrades Integra LifeSciences (IART) to Market Perform

October 30, 2017 12:29 AM EDT

Wells Fargo downgraded Integra LifeSciences (NASDAQ: IART) from Outperform to Market Perform with a price target of $46.00.

The analyst believes the company organic growth will come in below the industry average over the coming 12 months on the heels of fresh competition, the acquisition... More

JPMorgan Downgrades Integra LifeSciences (IART) to Neutral

October 27, 2017 4:41 AM EDT

JPMorgan downgraded Integra LifeSciences (NASDAQ: IART) from Overweight to Neutral with a price target of $44.00 (from $58.00).

Analyst Robbie Marcus cites a deteriorating base business and lowered growth outlook for the downgrade. The analyst fails to see a justification for a premium anymore noting growth degradation... More